Literature DB >> 25695806

UK Renal Registry 17th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2013: National and Centre-specific Analyses.

Anirudh Rao1, Anna Casula, Clare Castledine.   

Abstract

INTRODUCTION: This chapter describes the characteristics of adult patients on renal replacement therapy (RRT) in the UK in 2013.
METHODS: Data were electronically collected from all 71 renal centres within the UK. A series of cross sectional and longitudinal analyses were performed to describe the demographics of prevalent RRT patients in 2013 at centre and national level.
RESULTS: There were 56,940 adult patients receiving RRT in the UK on 31st December 2013. The UK adult prevalence of RRT was 888 pmp which represented an annual increase of 4%,with transplantation the most common treatment modality(52%). There was variation between centres, Clinical Commissioning Groups and Health Boards. The number of patients increased by 1.2% for haemodialysis (HD) and 7.1% for functioning transplant but decreased 3.3% for peritoneal dialysis (PD). The number of patients receiving home HD has increased by 3% since 2012. Median RRT vintage for patients on HD was 3.4 years, PD 1.7 years and for transplant, 10.1 years. The median age of prevalent patients was 58 years (HD 67 years, PD 64 years, transplant 53 years)compared to 55 years in 2000. For all ages the prevalence rate in men exceeded that in women. The most common recorded renal diagnosis was glomerulonephritis (biopsy proven/not biopsy proven) (19%).
CONCLUSIONS: The HD and transplant population continued to expand; but the prevalent PD population continues to decline. There were national, regional and centre level variations in prevalence rates. This has continued implications for service planning and ensuring equity of care for RRT patients.

Entities:  

Mesh:

Year:  2015        PMID: 25695806     DOI: 10.1159/000370272

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  16 in total

1.  Expert's comment concerning Grand Rounds case entitled "Posterior lumbar fixation in a kidney transplant recipient-logistics and perioperative challenges" (Marcin Czyz, Sibylle Jürgens, Keith M. Rigg, Marrie O'Connor, Bronek M. Boszczyk).

Authors:  Matt Hall
Journal:  Eur Spine J       Date:  2015-07-08       Impact factor: 3.134

Review 2.  How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?

Authors:  Yot Teerawattananon; Alia Luz; Songyot Pilasant; Suteenoot Tangsathitkulchai; Sarocha Chootipongchaivat; Nattha Tritasavit; Inthira Yamabhai; Sripen Tantivess
Journal:  Health Res Policy Syst       Date:  2016-03-18

Review 3.  Ageing Renal Patients: We Need More Collaboration between Geriatric Services and Nephrology Departments.

Authors:  Helen Alston; Aine Burns
Journal:  Healthcare (Basel)       Date:  2015-10-30

4.  Investigating the effects of 6 months extended duration, in-centre nocturnal versus conventional haemodialysis treatment: a non-randomised, controlled feasibility study.

Authors:  Darren R Churchward; Matthew P M Graham-Brown; Robert Preston; Warren Pickering; Gerry P McCann; James O Burton
Journal:  BMJ Open       Date:  2016-09-08       Impact factor: 2.692

5.  Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom.

Authors:  Masao Iwagami; Laurie A Tomlinson; Kathryn E Mansfield; Anna Casula; Fergus J Caskey; Grant Aitken; Simon D S Fraser; Paul J Roderick; Dorothea Nitsch
Journal:  Nephrol Dial Transplant       Date:  2017-04-01       Impact factor: 5.992

6.  A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration.

Authors:  James R Smith; Norica Zimmer; Elizabeth Bell; Bernard G Francq; Alex McConnachie; Robert Mactier
Journal:  Am J Kidney Dis       Date:  2016-12-23       Impact factor: 8.860

7.  Illness Beliefs in End Stage Renal Disease and Associations with Self-Care Modality Choice.

Authors:  Anuradha Jayanti; Philip Foden; Alison Wearden; Sandip Mitra
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

8.  A 4-month programme of in-centre nocturnal haemodialysis was associated with improvements in patient outcomes.

Authors:  Matthew P M Graham-Brown; Darren R Churchward; Alice C Smith; Richard J Baines; James O Burton
Journal:  Clin Kidney J       Date:  2015-10-06

9.  A study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis.

Authors:  Karin Friedli; Michael Almond; Clara Day; Joseph Chilcot; Maria da Silva Gane; Andrew Davenport; Ayman Guirguis; Naomi Fineberg; Benjamin Spencer; David Wellsted; Ken Farrington
Journal:  BMC Nephrol       Date:  2015-10-26       Impact factor: 2.388

10.  Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005-13.

Authors:  Kate Birnie; Fergus Caskey; Yoav Ben-Shlomo; Jonathan A C Sterne; Julie Gilg; Dorothea Nitsch; Charles Tomson
Journal:  Nephrol Dial Transplant       Date:  2017-04-01       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.